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Calcifying nanoparticles (CNPs, nanobac-
teria, nanobacteria-like particles) were
discovered as cell culture contaminants
by Kajander et al. more than 25 years
ago, and the first results of their work
were published some years later (Kajander
et al., 1997; Kajander and Ciftçioglu,
1998). The nature of CNPs has been
obscured so far. Possibly representing
a new proposed class of living organ-
isms or inorganic nanostructures, CNPs
exist as coccoid, coccobacillar, or bacil-
lary particles of 80–500 nm in diameter,
consisting of a central cavity surrounded
by the hydroxyapatite shell, and pos-
sessing an ability to grow and divide
in culture medium forming biofilms.
The phenomenon of CNPs raised inten-
sive discussions amongst the scientific
community; there are active debates on
their nature and potential role in clinical
medicine. According to a number of fun-
damental and clinical studies, CNPs are
suspected to cause ectopic calcification-
related diseases such as atherosclerosis,
heart valve calcification, placental calcifi-
cation, nephrolithiasis, cholecystolithiasis,
type III chronic prostatitis/chronic pelvic
pain syndrome, and testicular microlithi-
asis. Electron microscopy is considered
to be a gold standard for the visualiza-
tion of CNPs; researchers usually observe
the colonies of CNPs after the culturing
in DMEM or RPMI-1640 for 4–8 weeks.
Other means used by multiple groups
for the detection of CNPs are various
serological methods, including ELISA,
immunohistochemistry, immunofluo-
rescence reaction, immunoblotting, and
Ouchterlony immunodiffusion. Although
PCR has been previously used to identify
possible genome of CNPs, there are doubts
on credibility of this method since primers
could have been designed based not on
putative genome sequences of CNPs but
on the genome sequences of contaminat-
ing bacteria. The general features of CNPs
are indicated in Table 1.
Since the beginning of 2012, when
our group published a comprehensive
review on the role of CNPs in biol-
ogy and medicine (Kutikhin et al., 2012),
a number of newer findings have been
reported. Currently, it is possible to divide
all researchers studying CNPs into three
groups: (1) those that presume that CNPs
are living organisms (nanobacteria), (2)
those that consider them as culprits of
pathological calcification, and (3) those
that completely reject their pathological
role and assume them as the result of phys-
iological calcification.
A group from China investigated
the role of CNPs in placental calcifica-
tion. The authors successfully isolated
and cultured CNPs from the major-
ity of calcified placental samples but
not from normal placental tissues, con-
cluding that CNPs are associated with
this pathology (Guo et al., 2012; Lu
et al., 2012a,b). Further, the authors also
detected nucleic acid-like materials
within individual CNPs in consistency
with previous results by Agababov et al.
(2007). Despite the fact that sequencing of
putative nanobacterial 16s rRNA was suc-
cessful, the obtained sequences were 99%
similar to Agrobacterium tumefaciens and
Rheinheimera spp., which suggests sam-
ple contamination (Guo et al., 2012; Lu
et al., 2012a,b). In addition, the researchers
speculated that genome of CNPs isolated
from calcified placental samples may dif-
fer from the putative genome of CNPs
isolated from human blood and other
sources (Guo et al., 2012); nevertheless,
it is arguable that this assumption can be
proved by in silico analysis whether CNPs
have nucleic acids or not.
The same research group recently car-
ried out a first investigation of the
impact of nanohydroxyapatites (nHAPs)
and CNPs on growth and viability of
cancer cells (Zhang et al., 2014). Both
nHAPs and CNPs had considerable cyto-
toxic effects on MDA-MB-231 breast can-
cer cell line, including altered size and
morphology, formation of large cytoplas-
mic vacuoles, inhibition of proliferation,
and induction of apoptosis (Zhang et al.,
2014). Importantly, CNPs caused more
pronounced cytotoxic effects as com-
pared to nHAPs, as they induced both
early and late apoptosis and necrosis,
whereas nHAPs triggered early apopto-
sis only (Zhang et al., 2014). After the
internalization of CNPs by cancer cells,
cell shrinkage, chromatin condensation,
nuclear fragmentation, nuclear dissolu-
tion, and the formation of apoptotic bod-
ies were detected, although nHAPs did not
exhibit such an effect (Zhang et al., 2014).
No cytotoxic effects were observed in the
untreated control group (Zhang et al.,
2014).
Another investigation on the role of
CNPs in calcification-related diseases was
performed by a group from Spain con-
cerning aortic valve calcification (Barba
et al., 2012). The authors successfully
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Table 1 | Properties of calcifying nanoparticles (CNPs).
Properties of calcifying nanoparticles
Morphological properties 80–500 nm in diameter (can pass through 100-nm filters)
Usually have coccoid, coccobacillar, or bacillar form, often remind mineralized igloo
Have hydroxyapatite shell, cellular-membranous structure, and central cavity
Can form microscopic colonies (>1mm in diameter) under the low concentration of nutrients in the
environment
Divide by binary fission, fragmentation, and gemmation
Can form thermoresistant biofilms
Tinctorial properties Gram-negative, can be stained by DNA-specific dyes (Hoechst 33258 at a concentration of 5μg/ml during
50min, propidium iodide, PicoGreen—they are specific after the filtration through 0.1–0.22μm pores, staining
after a demineralization is optimal), can be revealed by von Kossa staining, staining by 2% uranyl acetate
(possibly with lead citrate) can detect specific mucus on the hydroxyapatite shell, in the mineralized state can
be stained by alizarin red S, can be stained by phosphotungstic acid
Resistance and sensitivity Resistant to 90◦C heating during 1 h
Resistant to γ-irradiation up to 30 kGray
Resistant to 5% NaCl solution
In the mineralized state are resistant to lyzozyme, proteinase K, certain other proteinases, lipases, amylases,
alkali, ultrasound, X-ray, detergents, and solvents
Temperature under 37◦C suppresses replication and prevents biofilms formation
Resistant to wide spectrum of antimicrobial therapeutics: aminoglycosides (in pharmacological concentrations),
chloramphenicol, lincosamides, cephalosporins, macrolides, fluoroquinolones, glycopeptides (in
pharmacological concentrations), polymyxins, antituberculous agents, aminocyclitol, spectinomycin
Sensitive to tetracyclines, ampicillin, trimethoprim, trimethoprim-sulfamethoxazole, nitrofurantoin,
5-fluorouracil, cytosine arabinoside, antimycin A, sodium azide, potassium cyanide, bisphosphonates
(etidronate, clodronate), 6-aminocaproic acid, in vitro growth can be inhibited by EDTA, EGTA, and citrate
Culture properties Doubling time is 3 days, in media without serum—6 days
Passage can be performed in DMEM (Dulbecco’s modified Eagle’s medium) or RPMI-1640 independently of
the presence of serum
Optimal atmosphere for growth should contain 5% of CO2 and 95% of air
Sensitive to β-mercaptoethanol, which stimulates growth of anaerobes, but cannot be cultivated under the
strictly anaerobic conditions
Calcify when serum concentration in the culture media is lower than 5%
Cytotoxic for fibroblasts and lymphocytes
Biochemical properties Metabolism is 10,000 times slower than in E. coli
Incorporate uridine (into the expected nucleic acid), methionine, and aspartic acid (into the expected system of
protein biosynthesis)
Calcify under the physiological pH (7.4)
Urease negative
Detection methods Bacterioscopic (DNA-specific dyes Hoechst 33258, propidium iodide, PicoGreen, staining after a
demineralization is optimal) using scanning and transmission electron microscopy, von Kossa staining which is
specific for calcium compounds, staining by 2% uranyl acetate (possibly with lead citrate) to detect specific
mucus on the hydroxyapatite shell, staining by alizarin red S in the mineralized state, staining by
phosphotungstic acid, after the long-term cultivation light microscopy with von Kossa staining is possible to be
used for detection
Bacteriological (cultivation in DMEM or RPMI-1640 without serum under 37◦C during 4–6 weeks after the
filtration through 0.1–0.22μm pores), replication can be assessed by spectrophotometry (650 nm wavelength)
Serological CNP antigens and anti-CNP monoclonal antibodies 8/0 (to porin), 5/2 (to peptidoglycan) and 8D10
(to porin) of NanoBiotech Pharma, Tampa, FL, USA—ELISA, immunohistochemistry, immunofluorescence
reaction, immunoblotting, Ouchterlony immunodiffusion
Genomic (PCR), but there is doubt that existing primers are obtained on the basis of CNP nucleic acids, and not
on the basis of nucleic acids of contaminating bacteria
Proteomic (sodium dodecyl sulfate polyacrylamide gel electrophoresis with further identification of protein
bands by mass spectrometry)
(Continued)
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Table 1 | Continued
Properties of calcifying nanoparticles





type III chronic prostatitis/chronic
pelvic pain syndrome, and testicular
microlithiasis)
comET-therapy (tetracycline, EDTA, and mix of nutrients)
Abbreviations: CNPs, calcifying nanoparticles; EDTA, ethylenediaminetetraacetic acid; EGTA, ethyleneglycoltetraacetic acid; DMEM, Dulbecco’s modified Eagle’s
medium; RPMI-1640, Roswell Park Memorial Institute 1640 medium; ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction. Cited from
Kutikhin et al. (2012).
cultured and isolated CNPs from calcified
aortic valves but not from uncalcified con-
trol valves, showing a feasible pathologi-
cal role of CNPs; however, no metabolic
activity was observed in the samples, and
authors failed to detect CNPs’ presup-
posed nucleic acids by real-time PCR
(Barba et al., 2012).
Other researchers did not attempt to
extract CNPs from clinical specimens;
instead, they investigated the inorganic
properties of CNPs and conditions of their
formation.Wu et al. (2013a) demonstrated
that various charged elements and ions
may form mineralo-organic nanoparti-
cles (so-called bions) with bacteria-like
morphology and similar properties in
biological fluids. Upon formation, bions
precipitated with phosphate, accumulated
carbonate apatite, incorporated addi-
tional elements and thus reflected the
ionic milieu of the biological fluid in
which they formed (Wu et al., 2013a).
Bions were able to increase in size and
number and to be sub-cultured in fresh
culture medium (Wu et al., 2013a). So,
many morphological and cultural features
of bions are similar to ones typical for
CNPs. The authors suggested that bions
may represent a part of a physiological
cycle that regulates the function, trans-
port, and disposal of mineral ions in the
body, and the accumulation of bions may
cause pathological processes in the human
body under the conditions of altered cal-
cium homeostasis and disturbed clearance
mechanisms (Wu et al., 2013a). So, a pro-
posed hypothesis was that bions may form
under both physiological and pathological
conditions (Wu et al., 2013a). In addition,
the same research group suggested that
membrane vesicles secreted by various
cells may contain a number of serum
proteins and can induce hydroxyapatite
precipitation during incubation in cell
culture medium forming nanostruc-
tures which morphologically resemble
CNPs (Wu et al., 2013b). Treatment
of these membrane vesicles with anti-
phosphatidylserine antibodies resulted in
decrease of their mineral seeding activity
suggesting that phosphatidylserine may
provide nucleating sites for calcium phos-
phate deposition on the vesicles (Wu et al.,
2013b).
Using dynamic light scattering, Peng
et al. (2013) showed that serum and
ion concentrations within the physio-
logical range may form nanoparticles
below 100 nm in diameter which can be
phagocytosed by macrophages in a size-
independent manner. However, only large
nanoparticles or their aggregates were able
to induce the production of mitochon-
drial reactive oxygen species, caspase-1
activation, and secretion of interleukin-1β
and therefore cause inflammation (Peng
et al., 2013). In addition, the authors
found that the set of particle-bound
proteins does not depend on particle
size and curvature (Peng et al., 2013).
According to the work of Baum et al.
(2012), aggregates of hemoglobin and var-
ious salts from physiological environment
can also produce morphological struc-
tures resembling CNPs. Finally, Kumon
et al. investigated one of the original
CNP isolates from urinary stones (P-17)
(Kumon et al., 2014). The authors devel-
oped anti-P-17 IgM monoclonal anti-
bodies, CL-15, which were specific for
oxidized lipids, and combined immu-
noelectron microscopy with ultrastruc-
tural and elemental analysis (Kumon
et al., 2014). They suggested that lamellar
structures consisted of acidic/oxidized
lipids provided structural scaffolds for
carbonate apatite and that lipid peroxi-
dation induced by γ-irradiation of fetal
bovine serum (FBS) was a major cause of
CNP propagation (Kumon et al., 2014).
Moreover, it was proposed that oxidized
lipids may be a common platform for
ectopic calcification in atherosclerosis-
prone (ApoE−/−) mice, thus CNPs were
suggested to be by-products rather than
etiological agents of chronic inflammation
(Kumon et al., 2014). However, it was also
noted that propagation of CNPs largely
depended on the amount of oxidized lipids
available and therefore could play a role in
disease progression (Kumon et al., 2014).
However, it should be clearly stated that
distinct processes may lead to the forma-
tion of nanostructures which are morpho-
logically similar. Bions, hemoglobin-salt
aggregates and oxidized lipids with acid-
ified functional groups may lead to the
occurrence of nanomorphological phe-
nomenon called CNPs; however, there
is no reason to discount many stud-
ies where CNPs were significantly asso-
ciated with ectopic calcification-related
diseases. In patients with these diseases,
CNPs were detected significantly more fre-
quently by electron microscopy and cul-
tural features in comparison with control
samples. Therefore, despite the fact that
the emergence of CNPs can be due to phys-
iological processes such as hemoglobin-
salt aggregation, they can also form in
greater numbers under pathological con-
ditions such as alteration of metabolic
and mineral ion homeostasis or lipid per-
oxidation regardless of their nature, in
this case being the culprits of the ectopic
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calcification-related diseases. In addition,
as demonstrated by Peng et al. (2013),
large CNPs or their aggregates may cause
chronic inflammation which plays a major
role in the development of all these dis-
eases. They should not be by-products of
inflammation since: (a) injection of CNPs
caused artery calcification (Schwartz et al.,
2008), nephrolithiasis (Hu et al., 2010),
cholecystolithiasis (Wang et al., 2006), and
type III chronic prostatitis (Shen et al.,
2010) in animal models; (b) treatment
of CNPs by comET-therapy (tetracycline
HCl, EDTA, and mixture of nutrients) led
to significant decline of CNP detection
rate, decreased calcification, and substan-
tial therapeutic improvement in patients
with coronary artery disease (CAD) and
type III chronic prostatitis/chronic pelvic
pain syndrome (Maniscalco and Taylor,
2004; Shoskes et al., 2005; Zhou et al.,
2008). So, the phenomenon of CNPs def-
initely should be taken into account when
we talk about the etiology and pathogene-
sis of ectopic calcification-related diseases.
Regarding the hypothesis of CNPs as
of the smallest self-replicating life form
on Earth (nanobacteria), the absence of a
fairly accurately sequenced genome aborts
all discussions about their putative living
nature. Nevertheless, the diverse nature of
CNPs (bions, hemoglobin-salt aggregates,
products of lipid peroxidation, calcified
membrane vesicles, other inorganic enti-
ties) still leaves a place for speculations
that certain nanoscale organisms may also
be one of the entities of CNPs. However,
this suggestion should be interpreted with
caution.
From our point of view, immuno-
logical and cytotoxic properties of CNPs
are still underinvestigated in the light
of their potential pathogenic role. The
investigations of Zhang et al. (2014)
and Peng et al. (2013) are good exam-
ples of this kind; however, new studies
are clearly needed, particularly due to
increasing role of nanomedicine in clini-
cal practice (nanovesicles for drug delivery,
nanobiosensors for disease diagnosis, ther-
apeutic nanoparticles which possibly may
act as nucleation agents, etc.). Possibly, B
cells may produce antibodies to CNPs, at
least to large CNPs and their aggregates,
and it is necessary to clarify this issue
due to its feasible importance for under-
standing of the immune response against
CNPs and for their serological detection.
Moreover, anti-CNP antibodies may be of
distinct structure due to feasibly different
entities of CNPs, their different size and
different proteins coating them. In addi-
tion, the significance of CNPs as etiolog-
ical agents of ectopic calcification-related
diseases may be also tested in animal
models and clinical trials using anti-
CNP treatment. Notwithstanding, current
standards of CAD and peripheral artery
disease (PAD) therapy do not include
drugs specifically directed against the cal-
cification. Unfortunately, comET-therapy
which demonstrated certain clinical effi-
cacy in treatment of CAD and type
III chronic prostatitis/chronic pelvic pain
syndrome should not be used for a pro-
longed treatment due to the increasing
hazard of antibiotic resistance. Possibly,
larger clinical trials of comET-therapy ana-
logues that do not contain antibiotics but
include other calcium-chelating agents can
be worthwhile.
To conclude, these two years have
revealed some new facts about CNPs:
• CNPs can be formed by distinct entities
such as bions, hemoglobin-salt aggre-
gates, products of lipid peroxidation,
calcified membrane vesicles, other inor-
ganic entities, and possibly by living
organisms; all these entities may pos-
sess similar looking nanomorphological
structure;
• CNPs can be formed both under the
both physiological and pathological
conditions depending on their entity;
impairment of metabolic and mineral
ion homeostasis and lipid peroxida-
tionmay cause increased propagation of
CNPs in the human body that may be
a direct cause of ectopic calcification-
related diseases;
• Large CNPs or their aggregates may
cause chronic inflammation by the
enhanced production of mitochondrial
reactive oxygen species, cytokines, and
by activation of pro-apoptotic enzymes;
• CNPs and nHAPs possess a number
of cytotoxic effects on cancer cell lines
such as alteration of cell size and mor-
phology, inhibition of proliferation, and
induction of apoptosis;
• Placental calcification may be defi-
nitely added to the list of CNP-caused
pathologies.
What is clear is that at the present time
there is no universal theory that can
entirely characterize CNPs, their charac-
teristics, and biological/medical signifi-
cance. We should not disclaim the fact
that CNPs may form under the physiologi-
cal conditions; however, there is irrefutable
evidence that an appearance of CNPs in
the living organism may cause ectopic
calcification-related diseases, and CNPs
definitely should not be considered as just
physiological phenomenon. In addition,
the fact that CNPs are more likely to be
inorganic structures than life forms defi-
nitely should not cause underestimation of
their potential pathogenic role. No doubt,
further investigations will shed light on the
nature of CNPs, their biological proper-
ties, and their role in clinical medicine.
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